Thursday, October 15, 2009

Further Topline Results for Epratuzumab Phase IIb Study in Systemic Lupus Erythematosus (SLE) http://bit.ly/12FW5C
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)